COMMUNIQUÉS West-GlobeNewswire

InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com

24/04/2025 - 14:39

Offering Affordable Health and Wellness Products with Exclusive Grand Opening Specials ROSEVILLE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Via IBN -- InnerScope Hearing Technologies ( OTC: INND ) is proud to announce [...]

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

24/04/2025 - 14:45

CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and [...]

AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025

24/04/2025 - 15:00

VALENCIA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will host [...]

Inmagene Reports Topline Results from Phase 2a Study of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-life, in Patients with Alopecia Areata

24/04/2025 - 15:00

Treatment with three doses of 300 mg (Cohort 1) and 600 mg (Cohort 2) IMG-007 over four weeks resulted in a dose-related clinical activity of hair regrowth. Patients in Cohort 2 showed a sustained improvement in [...]

INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”

24/04/2025 - 15:00

SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to advanced treatment [...]

Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference

24/04/2025 - 15:00

– Data to be presented supports development of rademikibart for patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Advancing rapid clinical development plan for rademikibart; expect [...]

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

24/04/2025 - 15:00

HOUSTON, TX, April 24, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that [...]

The Love for Liam Foundation to Host the Fourth Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 2, 2025

24/04/2025 - 15:01

PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- The Love for Liam Foundation , a 501(c)(3) nonprofit that seeks to raise awareness for pediatric epilepsy and drive research funding, today announced the Fourth Annual [...]

iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial

24/04/2025 - 09:01

For immediate release iSTAR Medical’s MINIject ® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health confirmed and 38% IOP [...]

New survey shows that over 90% of animal owners trust and appreciate veterinary teams but underestimate the demands of the profession

24/04/2025 - 10:00

New survey data show 94% of animal owners appreciate the work of veterinarians 1 , compared to only 49% of veterinary professionals feeling their profession is appreciated, among other findings. 2 The survey confirms [...]

Composition of the Nomination Committee of Orion Corporation

24/04/2025 - 10:00

ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 24 APRIL 2025 at 11.00 EEST Composition of the Nomination Committee of Orion Corporation The Board of [...]

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225

24/04/2025 - 11:00

Garching / Munich, Germany and VANCOUVER, British Columbia, April 24, 2025 – ITM Isotope Technologies Munich SE (ITM) , a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9) , a clinical-stage [...]

RadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference Call

24/04/2025 - 12:00

LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]

Merus annonce l’acceptation de son résumé pour présentation au congrès annuel 2025 de l’ASCO®

24/04/2025 - 06:34

- Le pétosemtamab en association avec le pembrolizumab en traitement de première intention d'un CETC r/m PD-L1+ : premières données cliniques provisoires sélectionnées pour une présentation sous forme d’affiche - [...]

Addex Therapeutics to Release Full-Year 2024 Financial Results and Host Conference Call on April 25, 2025

24/04/2025 - 07:00

Geneva, Switzerland, April 24, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological [...]

[Ad hoc announcement pursuant to Art. 53 LR] Roche continues good momentum into 2025 with 6% (CER) sales growth in the first quarter

24/04/2025 - 07:00

Group sales grew by 6% 1 at constant exchange rates (CER; 7% in CHF), driven by high demand for newer medicines and diagnostic solutions. Pharmaceuticals Division sales rose by 8% (9% in CHF) on continued strong demand [...]

Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes

24/04/2025 - 07:00

Press release – No. 6 / 2025 Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes The Phase 2b ZUPREME-2 trial [...]

Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea

24/04/2025 - 07:15

Allschwil, Switzerland, April 24, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal [...]

Communiqué de presse : Sanofi : forte performance au T1 et confirmation des perspectives pour 2025

24/04/2025 - 07:30

Sanofi : forte performance au T1 et confirmation des perspectives pour 2025 Paris, le 24 avril 2025 Ventes du T1 en progression de 9,7 % à TCC 1 et BNPA 2 des activités de 1,79 euro Les ventes des nouveaux lancements [...]